{
    "success":  true,
    "requestId":  "64a395a7-a407-4a4a-bd73-0a053f9a7460",
    "molecule":  "Humira",
    "processingMode":  "cloud",
    "modelUsed":  "gpt-4",
    "results":  {
                    "request_id":  "64a395a7-a407-4a4a-bd73-0a053f9a7460",
                    "molecule":  "Humira",
                    "processing_mode":  "cloud",
                    "model_used":  "gpt-4",
                    "agents_executed":  [
                                            {
                                                "name":  "ClinicalAgent",
                                                "status":  "completed",
                                                "duration_ms":  1631.29
                                            },
                                            {
                                                "name":  "PatentAgent",
                                                "status":  "completed",
                                                "duration_ms":  637.48
                                            },
                                            {
                                                "name":  "IQVIAInsightsAgent",
                                                "status":  "completed",
                                                "duration_ms":  684.98
                                            },
                                            {
                                                "name":  "WebIntelligenceAgent",
                                                "status":  "completed",
                                                "duration_ms":  1436.89
                                            },
                                            {
                                                "name":  "EXIMAgent",
                                                "status":  "completed",
                                                "duration_ms":  1091.67
                                            },
                                            {
                                                "name":  "InternalKnowledgeAgent",
                                                "status":  "completed",
                                                "duration_ms":  545.4
                                            },
                                            {
                                                "name":  "RegulatoryComplianceAgent",
                                                "status":  "completed",
                                                "duration_ms":  0.26
                                            },
                                            {
                                                "name":  "PatientSentimentAgent",
                                                "status":  "completed",
                                                "duration_ms":  0.21
                                            },
                                            {
                                                "name":  "ESGSustainabilityAgent",
                                                "status":  "completed",
                                                "duration_ms":  1.15
                                            }
                                        ],
                    "clinical":  {
                                     "molecule":  "Humira",
                                     "analysis_date":  "2025-12-06T13:15:05.292884",
                                     "total_trials_found":  33,
                                     "active_trials":  12,
                                     "completed_trials":  23,
                                     "phase_distribution":  {
                                                                "phase_1":  11,
                                                                "phase_2":  10,
                                                                "phase_3":  11,
                                                                "phase_4":  6
                                                            },
                                     "current_indications":  [
                                                                 "Multiple Sclerosis",
                                                                 "Crohn\u0027s Disease",
                                                                 "Rheumatoid Arthritis",
                                                                 "Non-Small Cell Lung Cancer"
                                                             ],
                                     "potential_new_indications":  [
                                                                       "Alzheimer\u0027s Disease",
                                                                       "Type 2 Diabetes",
                                                                       "Chronic Kidney Disease",
                                                                       "Rheumatoid Arthritis"
                                                                   ],
                                     "safety_score":  8.4,
                                     "adverse_events":  [
                                                            {
                                                                "event":  "Headache",
                                                                "frequency":  "Common",
                                                                "severity":  "Mild"
                                                            },
                                                            {
                                                                "event":  "Dizziness",
                                                                "frequency":  "Uncommon",
                                                                "severity":  "Mild"
                                                            },
                                                            {
                                                                "event":  "Rash",
                                                                "frequency":  "Uncommon",
                                                                "severity":  "Moderate"
                                                            }
                                                        ],
                                     "black_box_warning":  false,
                                     "efficacy_rating":  "Moderate",
                                     "primary_endpoint_success_rate":  "55%",
                                     "regulatory_status":  {
                                                               "fda":  "Under Review",
                                                               "ema":  "Under Review",
                                                               "pmda":  "Approved"
                                                           },
                                     "agent":  "ClinicalAgent",
                                     "version":  "1.0.0",
                                     "model_used":  "gpt-4",
                                     "processing_time_ms":  1631.29
                                 },
                    "patent":  {
                                   "molecule":  "Humira",
                                   "analysis_date":  "2025-12-06T13:15:05.930856",
                                   "total_patents":  29,
                                   "active_patents":  11,
                                   "pending_applications":  10,
                                   "earliest_expiration":  "2028-02-13",
                                   "latest_expiration":  "2031-11-01",
                                   "patent_term_extensions":  false,
                                   "freedom_to_operate":  "Clear",
                                   "fto_score":  7.6,
                                   "blocking_patents":  0,
                                   "key_patent_holders":  [
                                                              {
                                                                  "company":  "Pfizer",
                                                                  "patent_count":  7,
                                                                  "key_claims":  "Composition"
                                                              },
                                                              {
                                                                  "company":  "Novartis",
                                                                  "patent_count":  7,
                                                                  "key_claims":  "Composition"
                                                              },
                                                              {
                                                                  "company":  "Sanofi",
                                                                  "patent_count":  5,
                                                                  "key_claims":  "Formulation"
                                                              }
                                                          ],
                                   "licensing_opportunities":  "Available",
                                   "geographic_coverage":  {
                                                               "us":  true,
                                                               "eu":  true,
                                                               "japan":  true,
                                                               "china":  true,
                                                               "row":  true
                                                           },
                                   "ip_risk_level":  "Medium",
                                   "litigation_history":  4,
                                   "strategy_recommendations":  [
                                                                    "Evaluate design-around strategies for blocking claims",
                                                                    "Conduct detailed FTO analysis before Phase 3",
                                                                    "Explore patent term extension opportunities"
                                                                ],
                                   "agent":  "PatentAgent",
                                   "version":  "1.0.0",
                                   "model_used":  "gpt-4",
                                   "processing_time_ms":  637.48
                               },
                    "iqvia":  {
                                  "molecule":  "Humira",
                                  "analysis_date":  "2025-12-06T13:15:06.616341",
                                  "therapy_area":  "neurology",
                                  "market_size":  {
                                                      "therapy_area_market_usd_bn":  56.26,
                                                      "total_market_usd_bn":  56.26,
                                                      "molecule_market_usd_bn":  6.93,
                                                      "molecule_market_share":  "12.3%",
                                                      "market_growth_rate":  "8.5%",
                                                      "market_maturity":  "Emerging",
                                                      "market_size_ranking":  "#9 in Neurology"
                                                  },
                                  "global_market_size_usd_bn":  56.26,
                                  "cagr_analysis":  {
                                                        "five_year_cagr":  "8.5%",
                                                        "historical_cagr_3y":  "8.4%",
                                                        "projected_cagr_5y":  "8.6%",
                                                        "cagr_breakdown":  {
                                                                               "volume_growth":  "3.4%",
                                                                               "price_growth":  "2.5%",
                                                                               "mix_improvement":  "2.5%"
                                                                           },
                                                        "cagr_table":  [
                                                                           {
                                                                               "period":  "2020-2022",
                                                                               "cagr":  "7.7%",
                                                                               "driver":  "COVID impact"
                                                                           },
                                                                           {
                                                                               "period":  "2022-2024",
                                                                               "cagr":  "9.4%",
                                                                               "driver":  "Recovery \u0026 new launches"
                                                                           },
                                                                           {
                                                                               "period":  "2024-2026F",
                                                                               "cagr":  "8.5%",
                                                                               "driver":  "Normalized growth"
                                                                           },
                                                                           {
                                                                               "period":  "2026-2028F",
                                                                               "cagr":  "8.1%",
                                                                               "driver":  "Maturation"
                                                                           }
                                                                       ],
                                                        "growth_drivers":  [
                                                                               "Aging population demographics",
                                                                               "Increasing disease prevalence",
                                                                               "Novel therapy adoption",
                                                                               "Emerging market expansion"
                                                                           ]
                                                    },
                                  "five_year_cagr":  "8.5%",
                                  "sales_trends":  {
                                                       "quarterly_sales":  [
                                                                               {
                                                                                   "quarter":  "Q1\u002723",
                                                                                   "sales_usd_million":  1963.6
                                                                               },
                                                                               {
                                                                                   "quarter":  "Q2\u002723",
                                                                                   "sales_usd_million":  2013.6
                                                                               },
                                                                               {
                                                                                   "quarter":  "Q3\u002723",
                                                                                   "sales_usd_million":  1908.4
                                                                               },
                                                                               {
                                                                                   "quarter":  "Q4\u002723",
                                                                                   "sales_usd_million":  1957.8
                                                                               },
                                                                               {
                                                                                   "quarter":  "Q1\u002724",
                                                                                   "sales_usd_million":  2025.6
                                                                               },
                                                                               {
                                                                                   "quarter":  "Q2\u002724",
                                                                                   "sales_usd_million":  2020.5
                                                                               },
                                                                               {
                                                                                   "quarter":  "Q3\u002724",
                                                                                   "sales_usd_million":  2174.7
                                                                               },
                                                                               {
                                                                                   "quarter":  "Q4\u002724",
                                                                                   "sales_usd_million":  2048.4
                                                                               }
                                                                           ],
                                                       "trend_direction":  "Moderate Growth ↗",
                                                       "yoy_growth":  "12%",
                                                       "qoq_growth":  "10%",
                                                       "seasonality_impact":  "Low",
                                                       "sales_chart_data":  {
                                                                                "labels":  [
                                                                                               "Q1\u002723",
                                                                                               "Q2\u002723",
                                                                                               "Q3\u002723",
                                                                                               "Q4\u002723",
                                                                                               "Q1\u002724",
                                                                                               "Q2\u002724",
                                                                                               "Q3\u002724",
                                                                                               "Q4\u002724"
                                                                                           ],
                                                                                "values":  [
                                                                                               1963.6,
                                                                                               2013.6,
                                                                                               1908.4,
                                                                                               1957.8,
                                                                                               2025.6,
                                                                                               2020.5,
                                                                                               2174.7,
                                                                                               2048.4
                                                                                           ]
                                                                            }
                                                   },
                                  "sales_trend_direction":  "Moderate Growth ↗",
                                  "volume_shifts":  [
                                                        {
                                                            "shift_from":  "Hospital",
                                                            "shift_to":  "Retail/Specialty",
                                                            "shift_magnitude":  "12%",
                                                            "driver":  "Shift to outpatient care",
                                                            "impact_timeline":  "3 years",
                                                            "market_impact_usd_bn":  1.38
                                                        },
                                                        {
                                                            "shift_from":  "Oral Tablet",
                                                            "shift_to":  "Extended Release",
                                                            "shift_magnitude":  "17%",
                                                            "driver":  "Improved compliance",
                                                            "impact_timeline":  "2 years",
                                                            "market_impact_usd_bn":  1.39
                                                        },
                                                        {
                                                            "shift_from":  "Monotherapy",
                                                            "shift_to":  "Combination",
                                                            "shift_magnitude":  "24%",
                                                            "driver":  "Enhanced outcomes",
                                                            "impact_timeline":  "4 years",
                                                            "market_impact_usd_bn":  0.87
                                                        }
                                                    ],
                                  "primary_shift":  {
                                                        "shift_from":  "Hospital",
                                                        "shift_to":  "Retail/Specialty",
                                                        "shift_magnitude":  "12%",
                                                        "driver":  "Shift to outpatient care",
                                                        "impact_timeline":  "3 years",
                                                        "market_impact_usd_bn":  1.38
                                                    },
                                  "competitive_landscape":  {
                                                                "top_5":  [
                                                                              {
                                                                                  "rank":  1,
                                                                                  "company":  "Sanofi",
                                                                                  "market_share":  "35%",
                                                                                  "key_product":  "Sanofi Core Product",
                                                                                  "yoy_share_change":  "+7pp"
                                                                              },
                                                                              {
                                                                                  "rank":  2,
                                                                                  "company":  "Johnson \u0026 Johnson",
                                                                                  "market_share":  "14%",
                                                                                  "key_product":  "Johnson \u0026 Johnson Star Product",
                                                                                  "yoy_share_change":  "+8pp"
                                                                              },
                                                                              {
                                                                                  "rank":  3,
                                                                                  "company":  "Novartis",
                                                                                  "market_share":  "22%",
                                                                                  "key_product":  "Novartis Lead Product",
                                                                                  "yoy_share_change":  "-5pp"
                                                                              },
                                                                              {
                                                                                  "rank":  4,
                                                                                  "company":  "Gilead",
                                                                                  "market_share":  "13%",
                                                                                  "key_product":  "Gilead Star Product",
                                                                                  "yoy_share_change":  "+1pp"
                                                                              },
                                                                              {
                                                                                  "rank":  5,
                                                                                  "company":  "Biogen",
                                                                                  "market_share":  "16%",
                                                                                  "key_product":  "Biogen Core Product",
                                                                                  "yoy_share_change":  "+8pp"
                                                                              }
                                                                          ],
                                                                "concentration":  "High",
                                                                "hhi_index":  2330,
                                                                "new_entrants_last_2y":  3,
                                                                "competitive_intensity":  "Medium",
                                                                "key_competitive_factors":  [
                                                                                                "Efficacy differentiation",
                                                                                                "Pricing strategy",
                                                                                                "Market access",
                                                                                                "Pipeline strength"
                                                                                            ]
                                                            },
                                  "top_5_competitors":  [
                                                            {
                                                                "rank":  1,
                                                                "company":  "Sanofi",
                                                                "market_share":  "35%",
                                                                "key_product":  "Sanofi Core Product",
                                                                "yoy_share_change":  "+7pp"
                                                            },
                                                            {
                                                                "rank":  2,
                                                                "company":  "Johnson \u0026 Johnson",
                                                                "market_share":  "14%",
                                                                "key_product":  "Johnson \u0026 Johnson Star Product",
                                                                "yoy_share_change":  "+8pp"
                                                            },
                                                            {
                                                                "rank":  3,
                                                                "company":  "Novartis",
                                                                "market_share":  "22%",
                                                                "key_product":  "Novartis Lead Product",
                                                                "yoy_share_change":  "-5pp"
                                                            },
                                                            {
                                                                "rank":  4,
                                                                "company":  "Gilead",
                                                                "market_share":  "13%",
                                                                "key_product":  "Gilead Star Product",
                                                                "yoy_share_change":  "+1pp"
                                                            },
                                                            {
                                                                "rank":  5,
                                                                "company":  "Biogen",
                                                                "market_share":  "16%",
                                                                "key_product":  "Biogen Core Product",
                                                                "yoy_share_change":  "+8pp"
                                                            }
                                                        ],
                                  "market_concentration":  "High",
                                  "market_segments":  {
                                                          "by_product_type":  [
                                                                                  {
                                                                                      "segment":  "Innovator/Branded",
                                                                                      "share":  "42%"
                                                                                  },
                                                                                  {
                                                                                      "segment":  "Generic",
                                                                                      "share":  "29%"
                                                                                  },
                                                                                  {
                                                                                      "segment":  "Biosimilar",
                                                                                      "share":  "19%"
                                                                                  }
                                                                              ],
                                                          "by_distribution":  [
                                                                                  {
                                                                                      "channel":  "Retail Pharmacy",
                                                                                      "share":  "30%"
                                                                                  },
                                                                                  {
                                                                                      "channel":  "Hospital",
                                                                                      "share":  "33%"
                                                                                  },
                                                                                  {
                                                                                      "channel":  "Specialty Pharmacy",
                                                                                      "share":  "23%"
                                                                                  },
                                                                                  {
                                                                                      "channel":  "Mail Order",
                                                                                      "share":  "10%"
                                                                                  }
                                                                              ],
                                                          "by_payer":  [
                                                                           {
                                                                               "payer":  "Commercial Insurance",
                                                                               "share":  "48%"
                                                                           },
                                                                           {
                                                                               "payer":  "Medicare",
                                                                               "share":  "29%"
                                                                           },
                                                                           {
                                                                               "payer":  "Medicaid",
                                                                               "share":  "16%"
                                                                           },
                                                                           {
                                                                               "payer":  "Self-Pay/Other",
                                                                               "share":  "6%"
                                                                           }
                                                                       ]
                                                      },
                                  "regional_breakdown":  {
                                                             "by_region":  [
                                                                               {
                                                                                   "region":  "North America",
                                                                                   "share":  "44%",
                                                                                   "growth":  "10%"
                                                                               },
                                                                               {
                                                                                   "region":  "Europe",
                                                                                   "share":  "25%",
                                                                                   "growth":  "7%"
                                                                               },
                                                                               {
                                                                                   "region":  "Asia-Pacific",
                                                                                   "share":  "15%",
                                                                                   "growth":  "18%"
                                                                               },
                                                                               {
                                                                                   "region":  "Latin America",
                                                                                   "share":  "4%",
                                                                                   "growth":  "12%"
                                                                               },
                                                                               {
                                                                                   "region":  "Rest of World",
                                                                                   "share":  "5%",
                                                                                   "growth":  "10%"
                                                                               }
                                                                           ],
                                                             "fastest_growing_region":  "Asia-Pacific",
                                                             "largest_market":  "North America",
                                                             "emerging_opportunities":  [
                                                                                            "China",
                                                                                            "India",
                                                                                            "Brazil"
                                                                                        ]
                                                         },
                                  "market_forecast":  {
                                                          "2025":  60.76,
                                                          "2026":  65.82,
                                                          "2027":  71.45,
                                                          "2028":  77.64,
                                                          "2030":  91.7
                                                      },
                                  "investment_metrics":  {
                                                             "market_attractiveness_score":  7.6,
                                                             "entry_barriers":  "Medium",
                                                             "profitability_index":  2.3,
                                                             "time_to_peak_sales_years":  6
                                                         },
                                  "data_sources":  [
                                                       "IQVIA MIDAS",
                                                       "IQVIA NSP",
                                                       "Symphony Health",
                                                       "Evaluate Pharma"
                                                   ],
                                  "agent":  "IQVIAInsightsAgent",
                                  "version":  "1.0.0",
                                  "model_used":  "gpt-4",
                                  "processing_time_ms":  684.98
                              },
                    "market":  {
                                   "molecule":  "Humira",
                                   "analysis_date":  "2025-12-06T13:15:06.616341",
                                   "therapy_area":  "neurology",
                                   "market_size":  {
                                                       "therapy_area_market_usd_bn":  56.26,
                                                       "total_market_usd_bn":  56.26,
                                                       "molecule_market_usd_bn":  6.93,
                                                       "molecule_market_share":  "12.3%",
                                                       "market_growth_rate":  "8.5%",
                                                       "market_maturity":  "Emerging",
                                                       "market_size_ranking":  "#9 in Neurology"
                                                   },
                                   "global_market_size_usd_bn":  56.26,
                                   "cagr_analysis":  {
                                                         "five_year_cagr":  "8.5%",
                                                         "historical_cagr_3y":  "8.4%",
                                                         "projected_cagr_5y":  "8.6%",
                                                         "cagr_breakdown":  {
                                                                                "volume_growth":  "3.4%",
                                                                                "price_growth":  "2.5%",
                                                                                "mix_improvement":  "2.5%"
                                                                            },
                                                         "cagr_table":  [
                                                                            {
                                                                                "period":  "2020-2022",
                                                                                "cagr":  "7.7%",
                                                                                "driver":  "COVID impact"
                                                                            },
                                                                            {
                                                                                "period":  "2022-2024",
                                                                                "cagr":  "9.4%",
                                                                                "driver":  "Recovery \u0026 new launches"
                                                                            },
                                                                            {
                                                                                "period":  "2024-2026F",
                                                                                "cagr":  "8.5%",
                                                                                "driver":  "Normalized growth"
                                                                            },
                                                                            {
                                                                                "period":  "2026-2028F",
                                                                                "cagr":  "8.1%",
                                                                                "driver":  "Maturation"
                                                                            }
                                                                        ],
                                                         "growth_drivers":  [
                                                                                "Aging population demographics",
                                                                                "Increasing disease prevalence",
                                                                                "Novel therapy adoption",
                                                                                "Emerging market expansion"
                                                                            ]
                                                     },
                                   "five_year_cagr":  "8.5%",
                                   "sales_trends":  {
                                                        "quarterly_sales":  [
                                                                                {
                                                                                    "quarter":  "Q1\u002723",
                                                                                    "sales_usd_million":  1963.6
                                                                                },
                                                                                {
                                                                                    "quarter":  "Q2\u002723",
                                                                                    "sales_usd_million":  2013.6
                                                                                },
                                                                                {
                                                                                    "quarter":  "Q3\u002723",
                                                                                    "sales_usd_million":  1908.4
                                                                                },
                                                                                {
                                                                                    "quarter":  "Q4\u002723",
                                                                                    "sales_usd_million":  1957.8
                                                                                },
                                                                                {
                                                                                    "quarter":  "Q1\u002724",
                                                                                    "sales_usd_million":  2025.6
                                                                                },
                                                                                {
                                                                                    "quarter":  "Q2\u002724",
                                                                                    "sales_usd_million":  2020.5
                                                                                },
                                                                                {
                                                                                    "quarter":  "Q3\u002724",
                                                                                    "sales_usd_million":  2174.7
                                                                                },
                                                                                {
                                                                                    "quarter":  "Q4\u002724",
                                                                                    "sales_usd_million":  2048.4
                                                                                }
                                                                            ],
                                                        "trend_direction":  "Moderate Growth ↗",
                                                        "yoy_growth":  "12%",
                                                        "qoq_growth":  "10%",
                                                        "seasonality_impact":  "Low",
                                                        "sales_chart_data":  {
                                                                                 "labels":  [
                                                                                                "Q1\u002723",
                                                                                                "Q2\u002723",
                                                                                                "Q3\u002723",
                                                                                                "Q4\u002723",
                                                                                                "Q1\u002724",
                                                                                                "Q2\u002724",
                                                                                                "Q3\u002724",
                                                                                                "Q4\u002724"
                                                                                            ],
                                                                                 "values":  [
                                                                                                1963.6,
                                                                                                2013.6,
                                                                                                1908.4,
                                                                                                1957.8,
                                                                                                2025.6,
                                                                                                2020.5,
                                                                                                2174.7,
                                                                                                2048.4
                                                                                            ]
                                                                             }
                                                    },
                                   "sales_trend_direction":  "Moderate Growth ↗",
                                   "volume_shifts":  [
                                                         {
                                                             "shift_from":  "Hospital",
                                                             "shift_to":  "Retail/Specialty",
                                                             "shift_magnitude":  "12%",
                                                             "driver":  "Shift to outpatient care",
                                                             "impact_timeline":  "3 years",
                                                             "market_impact_usd_bn":  1.38
                                                         },
                                                         {
                                                             "shift_from":  "Oral Tablet",
                                                             "shift_to":  "Extended Release",
                                                             "shift_magnitude":  "17%",
                                                             "driver":  "Improved compliance",
                                                             "impact_timeline":  "2 years",
                                                             "market_impact_usd_bn":  1.39
                                                         },
                                                         {
                                                             "shift_from":  "Monotherapy",
                                                             "shift_to":  "Combination",
                                                             "shift_magnitude":  "24%",
                                                             "driver":  "Enhanced outcomes",
                                                             "impact_timeline":  "4 years",
                                                             "market_impact_usd_bn":  0.87
                                                         }
                                                     ],
                                   "primary_shift":  {
                                                         "shift_from":  "Hospital",
                                                         "shift_to":  "Retail/Specialty",
                                                         "shift_magnitude":  "12%",
                                                         "driver":  "Shift to outpatient care",
                                                         "impact_timeline":  "3 years",
                                                         "market_impact_usd_bn":  1.38
                                                     },
                                   "competitive_landscape":  {
                                                                 "top_5":  [
                                                                               {
                                                                                   "rank":  1,
                                                                                   "company":  "Sanofi",
                                                                                   "market_share":  "35%",
                                                                                   "key_product":  "Sanofi Core Product",
                                                                                   "yoy_share_change":  "+7pp"
                                                                               },
                                                                               {
                                                                                   "rank":  2,
                                                                                   "company":  "Johnson \u0026 Johnson",
                                                                                   "market_share":  "14%",
                                                                                   "key_product":  "Johnson \u0026 Johnson Star Product",
                                                                                   "yoy_share_change":  "+8pp"
                                                                               },
                                                                               {
                                                                                   "rank":  3,
                                                                                   "company":  "Novartis",
                                                                                   "market_share":  "22%",
                                                                                   "key_product":  "Novartis Lead Product",
                                                                                   "yoy_share_change":  "-5pp"
                                                                               },
                                                                               {
                                                                                   "rank":  4,
                                                                                   "company":  "Gilead",
                                                                                   "market_share":  "13%",
                                                                                   "key_product":  "Gilead Star Product",
                                                                                   "yoy_share_change":  "+1pp"
                                                                               },
                                                                               {
                                                                                   "rank":  5,
                                                                                   "company":  "Biogen",
                                                                                   "market_share":  "16%",
                                                                                   "key_product":  "Biogen Core Product",
                                                                                   "yoy_share_change":  "+8pp"
                                                                               }
                                                                           ],
                                                                 "concentration":  "High",
                                                                 "hhi_index":  2330,
                                                                 "new_entrants_last_2y":  3,
                                                                 "competitive_intensity":  "Medium",
                                                                 "key_competitive_factors":  [
                                                                                                 "Efficacy differentiation",
                                                                                                 "Pricing strategy",
                                                                                                 "Market access",
                                                                                                 "Pipeline strength"
                                                                                             ]
                                                             },
                                   "top_5_competitors":  [
                                                             {
                                                                 "rank":  1,
                                                                 "company":  "Sanofi",
                                                                 "market_share":  "35%",
                                                                 "key_product":  "Sanofi Core Product",
                                                                 "yoy_share_change":  "+7pp"
                                                             },
                                                             {
                                                                 "rank":  2,
                                                                 "company":  "Johnson \u0026 Johnson",
                                                                 "market_share":  "14%",
                                                                 "key_product":  "Johnson \u0026 Johnson Star Product",
                                                                 "yoy_share_change":  "+8pp"
                                                             },
                                                             {
                                                                 "rank":  3,
                                                                 "company":  "Novartis",
                                                                 "market_share":  "22%",
                                                                 "key_product":  "Novartis Lead Product",
                                                                 "yoy_share_change":  "-5pp"
                                                             },
                                                             {
                                                                 "rank":  4,
                                                                 "company":  "Gilead",
                                                                 "market_share":  "13%",
                                                                 "key_product":  "Gilead Star Product",
                                                                 "yoy_share_change":  "+1pp"
                                                             },
                                                             {
                                                                 "rank":  5,
                                                                 "company":  "Biogen",
                                                                 "market_share":  "16%",
                                                                 "key_product":  "Biogen Core Product",
                                                                 "yoy_share_change":  "+8pp"
                                                             }
                                                         ],
                                   "market_concentration":  "High",
                                   "market_segments":  {
                                                           "by_product_type":  [
                                                                                   {
                                                                                       "segment":  "Innovator/Branded",
                                                                                       "share":  "42%"
                                                                                   },
                                                                                   {
                                                                                       "segment":  "Generic",
                                                                                       "share":  "29%"
                                                                                   },
                                                                                   {
                                                                                       "segment":  "Biosimilar",
                                                                                       "share":  "19%"
                                                                                   }
                                                                               ],
                                                           "by_distribution":  [
                                                                                   {
                                                                                       "channel":  "Retail Pharmacy",
                                                                                       "share":  "30%"
                                                                                   },
                                                                                   {
                                                                                       "channel":  "Hospital",
                                                                                       "share":  "33%"
                                                                                   },
                                                                                   {
                                                                                       "channel":  "Specialty Pharmacy",
                                                                                       "share":  "23%"
                                                                                   },
                                                                                   {
                                                                                       "channel":  "Mail Order",
                                                                                       "share":  "10%"
                                                                                   }
                                                                               ],
                                                           "by_payer":  [
                                                                            {
                                                                                "payer":  "Commercial Insurance",
                                                                                "share":  "48%"
                                                                            },
                                                                            {
                                                                                "payer":  "Medicare",
                                                                                "share":  "29%"
                                                                            },
                                                                            {
                                                                                "payer":  "Medicaid",
                                                                                "share":  "16%"
                                                                            },
                                                                            {
                                                                                "payer":  "Self-Pay/Other",
                                                                                "share":  "6%"
                                                                            }
                                                                        ]
                                                       },
                                   "regional_breakdown":  {
                                                              "by_region":  [
                                                                                {
                                                                                    "region":  "North America",
                                                                                    "share":  "44%",
                                                                                    "growth":  "10%"
                                                                                },
                                                                                {
                                                                                    "region":  "Europe",
                                                                                    "share":  "25%",
                                                                                    "growth":  "7%"
                                                                                },
                                                                                {
                                                                                    "region":  "Asia-Pacific",
                                                                                    "share":  "15%",
                                                                                    "growth":  "18%"
                                                                                },
                                                                                {
                                                                                    "region":  "Latin America",
                                                                                    "share":  "4%",
                                                                                    "growth":  "12%"
                                                                                },
                                                                                {
                                                                                    "region":  "Rest of World",
                                                                                    "share":  "5%",
                                                                                    "growth":  "10%"
                                                                                }
                                                                            ],
                                                              "fastest_growing_region":  "Asia-Pacific",
                                                              "largest_market":  "North America",
                                                              "emerging_opportunities":  [
                                                                                             "China",
                                                                                             "India",
                                                                                             "Brazil"
                                                                                         ]
                                                          },
                                   "market_forecast":  {
                                                           "2025":  60.76,
                                                           "2026":  65.82,
                                                           "2027":  71.45,
                                                           "2028":  77.64,
                                                           "2030":  91.7
                                                       },
                                   "investment_metrics":  {
                                                              "market_attractiveness_score":  7.6,
                                                              "entry_barriers":  "Medium",
                                                              "profitability_index":  2.3,
                                                              "time_to_peak_sales_years":  6
                                                          },
                                   "data_sources":  [
                                                        "IQVIA MIDAS",
                                                        "IQVIA NSP",
                                                        "Symphony Health",
                                                        "Evaluate Pharma"
                                                    ],
                                   "agent":  "IQVIAInsightsAgent",
                                   "version":  "1.0.0",
                                   "model_used":  "gpt-4",
                                   "processing_time_ms":  684.98
                               },
                    "web_intel":  {
                                      "molecule":  "Humira",
                                      "analysis_date":  "2025-12-06T13:15:08.053726",
                                      "scientific_publications":  {
                                                                      "total_publications":  3991,
                                                                      "publications_last_year":  190,
                                                                      "publications_last_30_days":  8,
                                                                      "recent_papers":  [
                                                                                            {
                                                                                                "title":  "Real-world evidence for Humira in clinical practice",
                                                                                                "journal":  "Cell",
                                                                                                "published_date":  "2025-11-14",
                                                                                                "pmid":  "36542398",
                                                                                                "impact_factor":  21.4,
                                                                                                "citation_count":  23,
                                                                                                "key_finding":  "Synergistic combination identified"
                                                                                            },
                                                                                            {
                                                                                                "title":  "Mechanism of action study reveals new targets for Humira",
                                                                                                "journal":  "Journal of Clinical Oncology",
                                                                                                "published_date":  "2025-11-09",
                                                                                                "pmid":  "32148711",
                                                                                                "impact_factor":  77.7,
                                                                                                "citation_count":  11,
                                                                                                "key_finding":  "Biomarker for patient selection discovered"
                                                                                            },
                                                                                            {
                                                                                                "title":  "Biomarker identification for Humira response prediction",
                                                                                                "journal":  "NEJM",
                                                                                                "published_date":  "2025-11-30",
                                                                                                "pmid":  "39394746",
                                                                                                "impact_factor":  50.3,
                                                                                                "citation_count":  29,
                                                                                                "key_finding":  "Synergistic combination identified"
                                                                                            },
                                                                                            {
                                                                                                "title":  "Novel therapeutic applications of Humira in metabolic disorders",
                                                                                                "journal":  "Science Translational Medicine",
                                                                                                "published_date":  "2025-12-03",
                                                                                                "pmid":  "33462199",
                                                                                                "impact_factor":  59.2,
                                                                                                "citation_count":  2,
                                                                                                "key_finding":  "Synergistic combination identified"
                                                                                            },
                                                                                            {
                                                                                                "title":  "Phase 2 results for Humira combination therapy show promise",
                                                                                                "journal":  "Cell",
                                                                                                "published_date":  "2025-11-09",
                                                                                                "pmid":  "39973373",
                                                                                                "impact_factor":  19.9,
                                                                                                "citation_count":  25,
                                                                                                "key_finding":  "Positive efficacy signal in Phase 2"
                                                                                            },
                                                                                            {
                                                                                                "title":  "Biomarker identification for Humira response prediction",
                                                                                                "journal":  "Science Translational Medicine",
                                                                                                "published_date":  "2025-11-17",
                                                                                                "pmid":  "30445455",
                                                                                                "impact_factor":  52.9,
                                                                                                "citation_count":  37,
                                                                                                "key_finding":  "Synergistic combination identified"
                                                                                            },
                                                                                            {
                                                                                                "title":  "Phase 2 results for Humira combination therapy show promise",
                                                                                                "journal":  "Cell",
                                                                                                "published_date":  "2025-11-19",
                                                                                                "pmid":  "37991680",
                                                                                                "impact_factor":  50.8,
                                                                                                "citation_count":  16,
                                                                                                "key_finding":  "Positive efficacy signal in Phase 2"
                                                                                            },
                                                                                            {
                                                                                                "title":  "Long-term safety profile of Humira: A retrospective analysis",
                                                                                                "journal":  "Journal of Clinical Oncology",
                                                                                                "published_date":  "2025-11-15",
                                                                                                "pmid":  "33420486",
                                                                                                "impact_factor":  38.6,
                                                                                                "citation_count":  9,
                                                                                                "key_finding":  "Novel mechanism identified"
                                                                                            }
                                                                                        ],
                                                                      "trending_topics":  [
                                                                                              "Humira + immunotherapy",
                                                                                              "Humira biomarkers",
                                                                                              "Humira resistance mechanisms",
                                                                                              "Humira combination strategies"
                                                                                          ],
                                                                      "publication_trend":  "Decreasing ↓"
                                                                  },
                                      "new_publications_30d":  8,
                                      "news_signals":  {
                                                           "news_items":  [
                                                                              {
                                                                                  "headline":  "Positive Phase 3 results announced for Humira",
                                                                                  "type":  "Clinical Results",
                                                                                  "source":  "Endpoints",
                                                                                  "date":  "2025-12-05",
                                                                                  "sentiment":  "Negative",
                                                                                  "impact_score":  6,
                                                                                  "url":  "https://news.example.com/pharma/26270"
                                                                              },
                                                                              {
                                                                                  "headline":  "New indication approved for Humira",
                                                                                  "type":  "Label Expansion",
                                                                                  "source":  "Endpoints",
                                                                                  "date":  "2025-12-04",
                                                                                  "sentiment":  "Neutral",
                                                                                  "impact_score":  2,
                                                                                  "url":  "https://news.example.com/pharma/97645"
                                                                              },
                                                                              {
                                                                                  "headline":  "FDA grants Fast Track designation to Humira",
                                                                                  "type":  "FDA Update",
                                                                                  "source":  "Endpoints",
                                                                                  "date":  "2025-12-04",
                                                                                  "sentiment":  "Neutral",
                                                                                  "impact_score":  2,
                                                                                  "url":  "https://news.example.com/pharma/74204"
                                                                              },
                                                                              {
                                                                                  "headline":  "Major pharma announces partnership for Humira development",
                                                                                  "type":  "Partnership",
                                                                                  "source":  "FiercePharma",
                                                                                  "date":  "2025-11-25",
                                                                                  "sentiment":  "Neutral",
                                                                                  "impact_score":  4,
                                                                                  "url":  "https://news.example.com/pharma/72865"
                                                                              },
                                                                              {
                                                                                  "headline":  "Generic version of Humira approved in EU",
                                                                                  "type":  "Market Entry",
                                                                                  "source":  "STAT News",
                                                                                  "date":  "2025-11-29",
                                                                                  "sentiment":  "Negative",
                                                                                  "impact_score":  9,
                                                                                  "url":  "https://news.example.com/pharma/36883"
                                                                              },
                                                                              {
                                                                                  "headline":  "VC firm invests $500M in Humira developer",
                                                                                  "type":  "Investment",
                                                                                  "source":  "Reuters",
                                                                                  "date":  "2025-11-30",
                                                                                  "sentiment":  "Negative",
                                                                                  "impact_score":  2,
                                                                                  "url":  "https://news.example.com/pharma/90396"
                                                                              }
                                                                          ],
                                                           "total_mentions_7d":  77,
                                                           "sentiment_distribution":  {
                                                                                          "positive":  0,
                                                                                          "neutral":  3,
                                                                                          "negative":  3
                                                                                      },
                                                           "trending_score":  45,
                                                           "key_themes":  [
                                                                              "Clinical development progress",
                                                                              "Commercial potential",
                                                                              "Competitive dynamics"
                                                                          ]
                                                       },
                                      "signal_strength":  "WEAK",
                                      "regulatory_updates":  {
                                                                 "updates":  [
                                                                                 {
                                                                                     "agency":  "WHO",
                                                                                     "event":  "Essential Medicines List inclusion",
                                                                                     "status":  "Under Review",
                                                                                     "date":  "2025-11-17",
                                                                                     "impact":  "Low",
                                                                                     "next_action_date":  "2026-01-26"
                                                                                 },
                                                                                 {
                                                                                     "agency":  "FDA",
                                                                                     "event":  "Breakthrough Therapy designation",
                                                                                     "status":  "Granted",
                                                                                     "date":  "2025-10-31",
                                                                                     "impact":  "Low",
                                                                                     "next_action_date":  "2026-03-27"
                                                                                 }
                                                                             ],
                                                                 "pending_decisions":  0,
                                                                 "risk_level":  "LOW",
                                                                 "upcoming_pdufa_dates":  [

                                                                                          ],
                                                                 "guideline_changes":  [

                                                                                       ]
                                                             },
                                      "regulatory_risk_level":  "LOW",
                                      "vision_ai_insights":  {
                                                                 "charts_analyzed":  4,
                                                                 "insights":  [
                                                                                  {
                                                                                      "figure_type":  "Waterfall Plot",
                                                                                      "extracted_insight":  "85% of patients showed tumor shrinkage; 35% achieved PR",
                                                                                      "data_source":  "Efficacy assessment figure",
                                                                                      "confidence":  0.9,
                                                                                      "clinical_significance":  "Medium"
                                                                                  },
                                                                                  {
                                                                                      "figure_type":  "Bar Chart",
                                                                                      "extracted_insight":  "ORR of 62% vs 35% for comparator (p\u003c0.001)",
                                                                                      "data_source":  "Response rate comparison",
                                                                                      "confidence":  0.91,
                                                                                      "clinical_significance":  "Medium"
                                                                                  },
                                                                                  {
                                                                                      "figure_type":  "Kaplan-Meier Curve",
                                                                                      "extracted_insight":  "Survival benefit observed with HR=0.65 (p\u003c0.001)",
                                                                                      "data_source":  "Phase 3 primary analysis",
                                                                                      "confidence":  0.94,
                                                                                      "clinical_significance":  "Medium"
                                                                                  },
                                                                                  {
                                                                                      "figure_type":  "Forest Plot",
                                                                                      "extracted_insight":  "Consistent benefit across subgroups; no heterogeneity",
                                                                                      "data_source":  "Subgroup analysis",
                                                                                      "confidence":  0.86,
                                                                                      "clinical_significance":  "High"
                                                                                  }
                                                                              ],
                                                                 "vision_model":  "GPT-4 Vision",
                                                                 "key_visual_findings":  [
                                                                                             "85% of patients showed tumor shrinkage; 35% achieved PR",
                                                                                             "ORR of 62% vs 35% for comparator (p\u003c0.001)"
                                                                                         ]
                                                             },
                                      "community_signals":  {
                                                                "twitter_mentions_7d":  492,
                                                                "linkedin_discussions":  58,
                                                                "reddit_threads":  8,
                                                                "key_influencers":  [
                                                                                        {
                                                                                            "name":  "Dr. Expert 0",
                                                                                            "platform":  "LinkedIn",
                                                                                            "followers":  95134,
                                                                                            "sentiment":  "Positive"
                                                                                        },
                                                                                        {
                                                                                            "name":  "Dr. Expert 1",
                                                                                            "platform":  "LinkedIn",
                                                                                            "followers":  91266,
                                                                                            "sentiment":  "Neutral"
                                                                                        },
                                                                                        {
                                                                                            "name":  "Dr. Expert 2",
                                                                                            "platform":  "Twitter/X",
                                                                                            "followers":  18595,
                                                                                            "sentiment":  "Positive"
                                                                                        }
                                                                                    ],
                                                                "community_sentiment":  "Mixed",
                                                                "trending_hashtags":  [
                                                                                          "#Humira",
                                                                                          "#DrugDiscovery",
                                                                                          "#Pharma"
                                                                                      ]
                                                            },
                                      "intelligence_summary":  {
                                                                   "overall_sentiment":  "Mixed",
                                                                   "key_developments":  [
                                                                                            "8 new publications in last 30 days",
                                                                                            "6 significant news events",
                                                                                            "2 regulatory updates"
                                                                                        ],
                                                                   "watch_points":  [
                                                                                        "Monitor upcoming PDUFA date",
                                                                                        "Track competitive pipeline developments",
                                                                                        "Follow KOL commentary on recent data"
                                                                                    ],
                                                                   "opportunity_score":  6.5,
                                                                   "last_updated":  "2025-12-06T13:15:08.053734"
                                                               },
                                      "alerts":  [
                                                     {
                                                         "type":  "NEWS_ALERT",
                                                         "priority":  "HIGH",
                                                         "title":  "Generic version of Humira approved in EU",
                                                         "action":  "Review and assess strategic implications"
                                                     }
                                                 ],
                                      "data_sources":  [
                                                           "PubMed",
                                                           "ClinicalTrials.gov",
                                                           "FDA.gov",
                                                           "EMA.europa.eu",
                                                           "WHO",
                                                           "Reuters Health",
                                                           "FiercePharma",
                                                           "Endpoints News",
                                                           "STAT News"
                                                       ],
                                      "agent":  "WebIntelligenceAgent",
                                      "version":  "1.0.0",
                                      "model_used":  "gpt-4",
                                      "processing_time_ms":  1436.89
                                  },
                    "vision":  {
                                   "molecule":  "Humira",
                                   "analysis_date":  "2025-12-06T13:15:08.053726",
                                   "scientific_publications":  {
                                                                   "total_publications":  3991,
                                                                   "publications_last_year":  190,
                                                                   "publications_last_30_days":  8,
                                                                   "recent_papers":  [
                                                                                         {
                                                                                             "title":  "Real-world evidence for Humira in clinical practice",
                                                                                             "journal":  "Cell",
                                                                                             "published_date":  "2025-11-14",
                                                                                             "pmid":  "36542398",
                                                                                             "impact_factor":  21.4,
                                                                                             "citation_count":  23,
                                                                                             "key_finding":  "Synergistic combination identified"
                                                                                         },
                                                                                         {
                                                                                             "title":  "Mechanism of action study reveals new targets for Humira",
                                                                                             "journal":  "Journal of Clinical Oncology",
                                                                                             "published_date":  "2025-11-09",
                                                                                             "pmid":  "32148711",
                                                                                             "impact_factor":  77.7,
                                                                                             "citation_count":  11,
                                                                                             "key_finding":  "Biomarker for patient selection discovered"
                                                                                         },
                                                                                         {
                                                                                             "title":  "Biomarker identification for Humira response prediction",
                                                                                             "journal":  "NEJM",
                                                                                             "published_date":  "2025-11-30",
                                                                                             "pmid":  "39394746",
                                                                                             "impact_factor":  50.3,
                                                                                             "citation_count":  29,
                                                                                             "key_finding":  "Synergistic combination identified"
                                                                                         },
                                                                                         {
                                                                                             "title":  "Novel therapeutic applications of Humira in metabolic disorders",
                                                                                             "journal":  "Science Translational Medicine",
                                                                                             "published_date":  "2025-12-03",
                                                                                             "pmid":  "33462199",
                                                                                             "impact_factor":  59.2,
                                                                                             "citation_count":  2,
                                                                                             "key_finding":  "Synergistic combination identified"
                                                                                         },
                                                                                         {
                                                                                             "title":  "Phase 2 results for Humira combination therapy show promise",
                                                                                             "journal":  "Cell",
                                                                                             "published_date":  "2025-11-09",
                                                                                             "pmid":  "39973373",
                                                                                             "impact_factor":  19.9,
                                                                                             "citation_count":  25,
                                                                                             "key_finding":  "Positive efficacy signal in Phase 2"
                                                                                         },
                                                                                         {
                                                                                             "title":  "Biomarker identification for Humira response prediction",
                                                                                             "journal":  "Science Translational Medicine",
                                                                                             "published_date":  "2025-11-17",
                                                                                             "pmid":  "30445455",
                                                                                             "impact_factor":  52.9,
                                                                                             "citation_count":  37,
                                                                                             "key_finding":  "Synergistic combination identified"
                                                                                         },
                                                                                         {
                                                                                             "title":  "Phase 2 results for Humira combination therapy show promise",
                                                                                             "journal":  "Cell",
                                                                                             "published_date":  "2025-11-19",
                                                                                             "pmid":  "37991680",
                                                                                             "impact_factor":  50.8,
                                                                                             "citation_count":  16,
                                                                                             "key_finding":  "Positive efficacy signal in Phase 2"
                                                                                         },
                                                                                         {
                                                                                             "title":  "Long-term safety profile of Humira: A retrospective analysis",
                                                                                             "journal":  "Journal of Clinical Oncology",
                                                                                             "published_date":  "2025-11-15",
                                                                                             "pmid":  "33420486",
                                                                                             "impact_factor":  38.6,
                                                                                             "citation_count":  9,
                                                                                             "key_finding":  "Novel mechanism identified"
                                                                                         }
                                                                                     ],
                                                                   "trending_topics":  [
                                                                                           "Humira + immunotherapy",
                                                                                           "Humira biomarkers",
                                                                                           "Humira resistance mechanisms",
                                                                                           "Humira combination strategies"
                                                                                       ],
                                                                   "publication_trend":  "Decreasing ↓"
                                                               },
                                   "new_publications_30d":  8,
                                   "news_signals":  {
                                                        "news_items":  [
                                                                           {
                                                                               "headline":  "Positive Phase 3 results announced for Humira",
                                                                               "type":  "Clinical Results",
                                                                               "source":  "Endpoints",
                                                                               "date":  "2025-12-05",
                                                                               "sentiment":  "Negative",
                                                                               "impact_score":  6,
                                                                               "url":  "https://news.example.com/pharma/26270"
                                                                           },
                                                                           {
                                                                               "headline":  "New indication approved for Humira",
                                                                               "type":  "Label Expansion",
                                                                               "source":  "Endpoints",
                                                                               "date":  "2025-12-04",
                                                                               "sentiment":  "Neutral",
                                                                               "impact_score":  2,
                                                                               "url":  "https://news.example.com/pharma/97645"
                                                                           },
                                                                           {
                                                                               "headline":  "FDA grants Fast Track designation to Humira",
                                                                               "type":  "FDA Update",
                                                                               "source":  "Endpoints",
                                                                               "date":  "2025-12-04",
                                                                               "sentiment":  "Neutral",
                                                                               "impact_score":  2,
                                                                               "url":  "https://news.example.com/pharma/74204"
                                                                           },
                                                                           {
                                                                               "headline":  "Major pharma announces partnership for Humira development",
                                                                               "type":  "Partnership",
                                                                               "source":  "FiercePharma",
                                                                               "date":  "2025-11-25",
                                                                               "sentiment":  "Neutral",
                                                                               "impact_score":  4,
                                                                               "url":  "https://news.example.com/pharma/72865"
                                                                           },
                                                                           {
                                                                               "headline":  "Generic version of Humira approved in EU",
                                                                               "type":  "Market Entry",
                                                                               "source":  "STAT News",
                                                                               "date":  "2025-11-29",
                                                                               "sentiment":  "Negative",
                                                                               "impact_score":  9,
                                                                               "url":  "https://news.example.com/pharma/36883"
                                                                           },
                                                                           {
                                                                               "headline":  "VC firm invests $500M in Humira developer",
                                                                               "type":  "Investment",
                                                                               "source":  "Reuters",
                                                                               "date":  "2025-11-30",
                                                                               "sentiment":  "Negative",
                                                                               "impact_score":  2,
                                                                               "url":  "https://news.example.com/pharma/90396"
                                                                           }
                                                                       ],
                                                        "total_mentions_7d":  77,
                                                        "sentiment_distribution":  {
                                                                                       "positive":  0,
                                                                                       "neutral":  3,
                                                                                       "negative":  3
                                                                                   },
                                                        "trending_score":  45,
                                                        "key_themes":  [
                                                                           "Clinical development progress",
                                                                           "Commercial potential",
                                                                           "Competitive dynamics"
                                                                       ]
                                                    },
                                   "signal_strength":  "WEAK",
                                   "regulatory_updates":  {
                                                              "updates":  [
                                                                              {
                                                                                  "agency":  "WHO",
                                                                                  "event":  "Essential Medicines List inclusion",
                                                                                  "status":  "Under Review",
                                                                                  "date":  "2025-11-17",
                                                                                  "impact":  "Low",
                                                                                  "next_action_date":  "2026-01-26"
                                                                              },
                                                                              {
                                                                                  "agency":  "FDA",
                                                                                  "event":  "Breakthrough Therapy designation",
                                                                                  "status":  "Granted",
                                                                                  "date":  "2025-10-31",
                                                                                  "impact":  "Low",
                                                                                  "next_action_date":  "2026-03-27"
                                                                              }
                                                                          ],
                                                              "pending_decisions":  0,
                                                              "risk_level":  "LOW",
                                                              "upcoming_pdufa_dates":  [

                                                                                       ],
                                                              "guideline_changes":  [

                                                                                    ]
                                                          },
                                   "regulatory_risk_level":  "LOW",
                                   "vision_ai_insights":  {
                                                              "charts_analyzed":  4,
                                                              "insights":  [
                                                                               {
                                                                                   "figure_type":  "Waterfall Plot",
                                                                                   "extracted_insight":  "85% of patients showed tumor shrinkage; 35% achieved PR",
                                                                                   "data_source":  "Efficacy assessment figure",
                                                                                   "confidence":  0.9,
                                                                                   "clinical_significance":  "Medium"
                                                                               },
                                                                               {
                                                                                   "figure_type":  "Bar Chart",
                                                                                   "extracted_insight":  "ORR of 62% vs 35% for comparator (p\u003c0.001)",
                                                                                   "data_source":  "Response rate comparison",
                                                                                   "confidence":  0.91,
                                                                                   "clinical_significance":  "Medium"
                                                                               },
                                                                               {
                                                                                   "figure_type":  "Kaplan-Meier Curve",
                                                                                   "extracted_insight":  "Survival benefit observed with HR=0.65 (p\u003c0.001)",
                                                                                   "data_source":  "Phase 3 primary analysis",
                                                                                   "confidence":  0.94,
                                                                                   "clinical_significance":  "Medium"
                                                                               },
                                                                               {
                                                                                   "figure_type":  "Forest Plot",
                                                                                   "extracted_insight":  "Consistent benefit across subgroups; no heterogeneity",
                                                                                   "data_source":  "Subgroup analysis",
                                                                                   "confidence":  0.86,
                                                                                   "clinical_significance":  "High"
                                                                               }
                                                                           ],
                                                              "vision_model":  "GPT-4 Vision",
                                                              "key_visual_findings":  [
                                                                                          "85% of patients showed tumor shrinkage; 35% achieved PR",
                                                                                          "ORR of 62% vs 35% for comparator (p\u003c0.001)"
                                                                                      ]
                                                          },
                                   "community_signals":  {
                                                             "twitter_mentions_7d":  492,
                                                             "linkedin_discussions":  58,
                                                             "reddit_threads":  8,
                                                             "key_influencers":  [
                                                                                     {
                                                                                         "name":  "Dr. Expert 0",
                                                                                         "platform":  "LinkedIn",
                                                                                         "followers":  95134,
                                                                                         "sentiment":  "Positive"
                                                                                     },
                                                                                     {
                                                                                         "name":  "Dr. Expert 1",
                                                                                         "platform":  "LinkedIn",
                                                                                         "followers":  91266,
                                                                                         "sentiment":  "Neutral"
                                                                                     },
                                                                                     {
                                                                                         "name":  "Dr. Expert 2",
                                                                                         "platform":  "Twitter/X",
                                                                                         "followers":  18595,
                                                                                         "sentiment":  "Positive"
                                                                                     }
                                                                                 ],
                                                             "community_sentiment":  "Mixed",
                                                             "trending_hashtags":  [
                                                                                       "#Humira",
                                                                                       "#DrugDiscovery",
                                                                                       "#Pharma"
                                                                                   ]
                                                         },
                                   "intelligence_summary":  {
                                                                "overall_sentiment":  "Mixed",
                                                                "key_developments":  [
                                                                                         "8 new publications in last 30 days",
                                                                                         "6 significant news events",
                                                                                         "2 regulatory updates"
                                                                                     ],
                                                                "watch_points":  [
                                                                                     "Monitor upcoming PDUFA date",
                                                                                     "Track competitive pipeline developments",
                                                                                     "Follow KOL commentary on recent data"
                                                                                 ],
                                                                "opportunity_score":  6.5,
                                                                "last_updated":  "2025-12-06T13:15:08.053734"
                                                            },
                                   "alerts":  [
                                                  {
                                                      "type":  "NEWS_ALERT",
                                                      "priority":  "HIGH",
                                                      "title":  "Generic version of Humira approved in EU",
                                                      "action":  "Review and assess strategic implications"
                                                  }
                                              ],
                                   "data_sources":  [
                                                        "PubMed",
                                                        "ClinicalTrials.gov",
                                                        "FDA.gov",
                                                        "EMA.europa.eu",
                                                        "WHO",
                                                        "Reuters Health",
                                                        "FiercePharma",
                                                        "Endpoints News",
                                                        "STAT News"
                                                    ],
                                   "agent":  "WebIntelligenceAgent",
                                   "version":  "1.0.0",
                                   "model_used":  "gpt-4",
                                   "processing_time_ms":  1436.89
                               },
                    "exim":  {
                                 "molecule":  "Humira",
                                 "analysis_date":  "2025-12-06T13:15:09.145648",
                                 "global_trade_flows":  [
                                                            {
                                                                "origin":  "China",
                                                                "destination":  "India",
                                                                "product_type":  "API",
                                                                "volume_mt":  300.8,
                                                                "value_usd_million":  5.63,
                                                                "yoy_growth":  "-3%",
                                                                "trend":  "↓ Declining"
                                                            },
                                                            {
                                                                "origin":  "China",
                                                                "destination":  "USA",
                                                                "product_type":  "API",
                                                                "volume_mt":  184.1,
                                                                "value_usd_million":  42.58,
                                                                "yoy_growth":  "17%",
                                                                "trend":  "↑ Growing"
                                                            },
                                                            {
                                                                "origin":  "India",
                                                                "destination":  "USA",
                                                                "product_type":  "Formulation",
                                                                "volume_mt":  488.9,
                                                                "value_usd_million":  47.14,
                                                                "yoy_growth":  "7%",
                                                                "trend":  "→ Stable"
                                                            },
                                                            {
                                                                "origin":  "India",
                                                                "destination":  "Europe",
                                                                "product_type":  "Formulation",
                                                                "volume_mt":  334.1,
                                                                "value_usd_million":  47.36,
                                                                "yoy_growth":  "-10%",
                                                                "trend":  "↓ Declining"
                                                            },
                                                            {
                                                                "origin":  "Europe",
                                                                "destination":  "USA",
                                                                "product_type":  "Branded",
                                                                "volume_mt":  106.2,
                                                                "value_usd_million":  46.92,
                                                                "yoy_growth":  "14%",
                                                                "trend":  "↑ Growing"
                                                            },
                                                            {
                                                                "origin":  "China",
                                                                "destination":  "Europe",
                                                                "product_type":  "Intermediate",
                                                                "volume_mt":  398.4,
                                                                "value_usd_million":  21.73,
                                                                "yoy_growth":  "-15%",
                                                                "trend":  "↑ Growing"
                                                            }
                                                        ],
                                 "total_trade_volume_mt":  4556.7,
                                 "trade_value_usd_million":  451.9,
                                 "sourcing_hubs":  [
                                                       {
                                                           "country":  "China",
                                                           "market_share_percent":  74,
                                                           "specialization":  "API Manufacturing",
                                                           "cost_competitiveness_index":  1,
                                                           "key_manufacturers":  22,
                                                           "quality_rating":  "A",
                                                           "lead_time_weeks":  6
                                                       },
                                                       {
                                                           "country":  "India",
                                                           "market_share_percent":  29,
                                                           "specialization":  "Formulation \u0026 API",
                                                           "cost_competitiveness_index":  1.15,
                                                           "key_manufacturers":  27,
                                                           "quality_rating":  "A",
                                                           "lead_time_weeks":  8
                                                       },
                                                       {
                                                           "country":  "Europe",
                                                           "market_share_percent":  -2,
                                                           "specialization":  "High-Value Intermediates",
                                                           "cost_competitiveness_index":  2.5,
                                                           "key_manufacturers":  19,
                                                           "quality_rating":  "A",
                                                           "lead_time_weeks":  5
                                                       },
                                                       {
                                                           "country":  "USA",
                                                           "market_share_percent":  -2,
                                                           "specialization":  "Specialty APIs",
                                                           "cost_competitiveness_index":  3,
                                                           "key_manufacturers":  39,
                                                           "quality_rating":  "A",
                                                           "lead_time_weeks":  14
                                                       }
                                                   ],
                                 "primary_source_country":  "China",
                                 "import_dependency":  {
                                                           "total_import_dependency":  "103%",
                                                           "primary_source":  {
                                                                                  "country":  "China",
                                                                                  "share":  "74%",
                                                                                  "trend":  "Decreasing"
                                                                              },
                                                           "secondary_source":  {
                                                                                    "country":  "India",
                                                                                    "share":  "29%",
                                                                                    "trend":  "Stable"
                                                                                },
                                                           "domestic_production":  {
                                                                                       "share":  "-3%",
                                                                                       "capacity_utilization":  "71%"
                                                                                   },
                                                           "import_dependency_table":  [
                                                                                           {
                                                                                               "region":  "Asia-Pacific",
                                                                                               "share":  "103%",
                                                                                               "risk":  "High"
                                                                                           },
                                                                                           {
                                                                                               "region":  "Europe",
                                                                                               "share":  "5%",
                                                                                               "risk":  "Low"
                                                                                           },
                                                                                           {
                                                                                               "region":  "Americas",
                                                                                               "share":  "5%",
                                                                                               "risk":  "Low"
                                                                                           },
                                                                                           {
                                                                                               "region":  "Others",
                                                                                               "share":  "4%",
                                                                                               "risk":  "Medium"
                                                                                           }
                                                                                       ]
                                                       },
                                 "dependency_risk_level":  "CRITICAL",
                                 "supply_risks":  [
                                                      {
                                                          "risk_type":  "Concentration Risk",
                                                          "severity":  "HIGH",
                                                          "description":  "China supplies 74% of global demand",
                                                          "mitigation":  "Develop alternative sourcing from India/Europe"
                                                      },
                                                      {
                                                          "risk_type":  "Geopolitical Risk",
                                                          "severity":  "HIGH",
                                                          "description":  "Trade tensions may affect API imports from primary source",
                                                          "mitigation":  "Establish strategic inventory buffers (6-month stock)"
                                                      },
                                                      {
                                                          "risk_type":  "Regulatory Compliance",
                                                          "severity":  "LOW",
                                                          "description":  "FDA warning letters to some manufacturers in sourcing region",
                                                          "mitigation":  "Qualify additional GMP-certified suppliers"
                                                      },
                                                      {
                                                          "risk_type":  "Logistics Disruption",
                                                          "severity":  "LOW",
                                                          "description":  "Port congestion and shipping delays impact delivery timelines",
                                                          "mitigation":  "Diversify shipping routes and maintain safety stock"
                                                      }
                                                  ],
                                 "overall_supply_risk":  "HIGH",
                                 "price_trends":  {
                                                      "current_price_usd_kg":  435.04,
                                                      "price_12_months_ago":  402.41,
                                                      "price_24_months_ago":  349.32,
                                                      "yoy_change":  "14%",
                                                      "price_forecast_12m":  443.88,
                                                      "price_drivers":  [
                                                                            "Raw material costs",
                                                                            "Energy prices"
                                                                        ]
                                                  },
                                 "price_volatility":  "High",
                                 "trade_volume_chart":  {
                                                            "chart_type":  "bar",
                                                            "title":  "Global Trade Volume - Humira",
                                                            "x_axis":  {
                                                                           "label":  "Year",
                                                                           "data":  [
                                                                                        2020,
                                                                                        2021,
                                                                                        2022,
                                                                                        2023,
                                                                                        2024,
                                                                                        2025
                                                                                    ]
                                                                       },
                                                            "y_axis":  {
                                                                           "label":  "Volume (MT)",
                                                                           "data":  [
                                                                                        2641.4,
                                                                                        2903.1,
                                                                                        2938.8,
                                                                                        2970.8,
                                                                                        3061.8,
                                                                                        4022.7
                                                                                    ]
                                                                       },
                                                            "annotations":  [
                                                                                {
                                                                                    "year":  2023,
                                                                                    "event":  "Supply chain normalization post-COVID"
                                                                                },
                                                                                {
                                                                                    "year":  2024,
                                                                                    "event":  "New capacity additions in India"
                                                                                }
                                                                            ],
                                                            "cagr_5year":  "13.5%"
                                                        },
                                 "regulatory_status":  {
                                                           "usfda_approved_sources":  10,
                                                           "eu_gmp_certified":  13,
                                                           "who_prequalified":  9
                                                       },
                                 "recommendations":  [
                                                         "🔴 URGENT: Reduce single-source dependency below 50%",
                                                         "📦 Establish strategic buffer inventory (6-12 months)",
                                                         "⚠️ Address Concentration Risk: Develop alternative sourcing from India/Europe",
                                                         "⚠️ Address Geopolitical Risk: Establish strategic inventory buffers (6-month stock)",
                                                         "🌍 Qualify at least 2 suppliers per critical API"
                                                     ],
                                 "data_sources":  [
                                                      "EXIM Trade Portal",
                                                      "ITC TradeMap",
                                                      "UN Comtrade",
                                                      "Pharmexcil"
                                                  ],
                                 "agent":  "EXIMAgent",
                                 "version":  "1.0.0",
                                 "model_used":  "gpt-4",
                                 "processing_time_ms":  1091.67
                             },
                    "internal":  {
                                     "molecule":  "Humira",
                                     "analysis_date":  "2025-12-06T13:15:09.691714",
                                     "secure_processing":  false,
                                     "llm_used":  "GPT-4 (Cloud)",
                                     "relevant_documents":  [
                                                                {
                                                                    "document_id":  "DOC001",
                                                                    "title":  "Oncology Strategy Deck 2024",
                                                                    "file_type":  "pptx",
                                                                    "department":  "Strategy",
                                                                    "date":  "2024-01-15",
                                                                    "relevance_score":  0.99,
                                                                    "snippet":  "Previous assessment of Humira highlighted competitive positioning advantages...",
                                                                    "page_references":  [
                                                                                            12
                                                                                        ]
                                                                },
                                                                {
                                                                    "document_id":  "DOC002",
                                                                    "title":  "Competitive Intelligence Report - Immunotherapy",
                                                                    "file_type":  "pdf",
                                                                    "department":  "Competitive Intelligence",
                                                                    "date":  "2024-03-20",
                                                                    "relevance_score":  0.81,
                                                                    "snippet":  "Our analysis of Humira indicates strong potential in the target indication...",
                                                                    "page_references":  [
                                                                                            30
                                                                                        ]
                                                                },
                                                                {
                                                                    "document_id":  "DOC005",
                                                                    "title":  "Market Access Strategy - Rare Disease",
                                                                    "file_type":  "pptx",
                                                                    "department":  "Market Access",
                                                                    "date":  "2024-05-05",
                                                                    "relevance_score":  0.57,
                                                                    "snippet":  "Strategic considerations for Humira include market access pathways and...",
                                                                    "page_references":  [
                                                                                            41,
                                                                                            6
                                                                                        ]
                                                                },
                                                                {
                                                                    "document_id":  "DOC003",
                                                                    "title":  "Due Diligence - Target Acquisition",
                                                                    "file_type":  "pdf",
                                                                    "department":  "BD\u0026L",
                                                                    "date":  "2024-02-28",
                                                                    "relevance_score":  0.35,
                                                                    "snippet":  "Our analysis of Humira indicates strong potential in the target indication...",
                                                                    "page_references":  [
                                                                                            31,
                                                                                            32
                                                                                        ]
                                                                }
                                                            ],
                                     "documents_found":  4,
                                     "rag_insights":  {
                                                          "total_insights":  3,
                                                          "insights":  [
                                                                           {
                                                                               "category":  "Market Opportunity",
                                                                               "insight":  "Previous market assessment valued opportunity at $8B",
                                                                               "confidence":  0.78,
                                                                               "source_count":  2
                                                                           },
                                                                           {
                                                                               "category":  "Competitive Analysis",
                                                                               "insight":  "Prior CI work identified 5 direct competitors in development",
                                                                               "confidence":  0.92,
                                                                               "source_count":  2
                                                                           },
                                                                           {
                                                                               "category":  "Strategic Positioning",
                                                                               "insight":  "Internal research suggests Humira has differentiation potential through novel mechanism",
                                                                               "confidence":  0.85,
                                                                               "source_count":  5
                                                                           }
                                                                       ],
                                                          "synthesis":  "Based on 4 internal documents, Humira has been previously evaluated with mixed signals. Key focus areas include competitive differentiation and regulatory strategy.",
                                                          "confidence_average":  0.85
                                                      },
                                     "historical_analysis":  [
                                                                 {
                                                                     "analysis_id":  "HIST5410",
                                                                     "date":  "2025-06-09",
                                                                     "type":  "Due Diligence",
                                                                     "conclusion":  "Deprioritized due to competitive landscape",
                                                                     "key_findings":  [
                                                                                          "Finding 1: Attractive market opportunity",
                                                                                          "Finding 2: Strong efficacy signal in preclinical",
                                                                                          "Finding 3: Strong efficacy signal in preclinical",
                                                                                          "Finding 4: Strong efficacy signal in preclinical"
                                                                                      ]
                                                                 },
                                                                 {
                                                                     "analysis_id":  "HIST2205",
                                                                     "date":  "2024-12-11",
                                                                     "type":  "Pipeline Evaluation",
                                                                     "conclusion":  "Deprioritized due to competitive landscape",
                                                                     "key_findings":  [
                                                                                          "Finding 1: Strong efficacy signal in preclinical",
                                                                                          "Finding 2: Complex regulatory pathway identified",
                                                                                          "Finding 3: Complex regulatory pathway identified"
                                                                                      ]
                                                                 }
                                                             ],
                                     "has_prior_research":  true,
                                     "knowledge_gaps":  [
                                                            {
                                                                "knowledge_area":  "Regulatory Strategy",
                                                                "gap_description":  "FDA feedback not documented",
                                                                "priority":  "High",
                                                                "recommended_action":  "Conduct regulatory strategy assessment",
                                                                "estimated_effort":  "4-6 weeks"
                                                            },
                                                            {
                                                                "knowledge_area":  "Competitive Intelligence",
                                                                "gap_description":  "Latest competitor pipeline updates needed",
                                                                "priority":  "Medium",
                                                                "recommended_action":  "Conduct competitive intelligence assessment",
                                                                "estimated_effort":  "4-6 weeks"
                                                            }
                                                        ],
                                     "cross_reference_summary":  {
                                                                     "documents_analyzed":  4,
                                                                     "common_themes":  [
                                                                                           "Competitive positioning",
                                                                                           "Market access strategy",
                                                                                           "Clinical development pathway"
                                                                                       ],
                                                                     "conflicting_viewpoints":  [

                                                                                                ],
                                                                     "recommendation":  "Consolidate findings into updated strategy document"
                                                                 },
                                     "security_info":  {
                                                           "data_residency":  "On-Premise",
                                                           "encryption":  "AES-256",
                                                           "access_logged":  true,
                                                           "user_permissions_verified":  true
                                                       },
                                     "agent":  "InternalKnowledgeAgent",
                                     "version":  "1.0.0",
                                     "model_used":  "gpt-4",
                                     "processing_time_ms":  545.4
                                 },
                    "regulatory":  {
                                       "agent":  "RegulatoryComplianceAgent",
                                       "molecule":  "Humira",
                                       "indication":  {
                                                          "provider":  "openai",
                                                          "model":  "gpt-4",
                                                          "api_key":  null,
                                                          "temperature":  0.7,
                                                          "max_tokens":  4096,
                                                          "privacy_level":  "standard",
                                                          "data_residency":  "cloud",
                                                          "capabilities":  {
                                                                               "complex_reasoning":  true,
                                                                               "multi_modal":  true,
                                                                               "context_window":  128000
                                                                           }
                                                      },
                                       "timestamp":  "2025-12-06T13:15:09.692521",
                                       "processing_time_ms":  0.26,
                                       "fda_orange_book":  {
                                                               "listed":  false,
                                                               "potential_rld":  null,
                                                               "generic_available":  false,
                                                               "exclusivity_opportunities":  [
                                                                                                 "New indication exclusivity (3 years)",
                                                                                                 "Pediatric exclusivity potential (6 months)",
                                                                                                 "Orphan drug designation possible (7 years)"
                                                                                             ]
                                                           },
                                       "black_box_warnings":  [

                                                              ],
                                       "warning_count":  0,
                                       "safety_risk_level":  "Low",
                                       "rejection_history":  [

                                                             ],
                                       "has_prior_rejections":  false,
                                       "recommended_pathway":  "505(b)(2) NDA",
                                       "pathway_rationale":  "Hybrid pathway referencing published literature",
                                       "estimated_timeline_months":  42,
                                       "pathway_complexity":  "Medium",
                                       "compliance_score":  100,
                                       "compliance_grade":  "A",
                                       "compliance_flags":  [

                                                            ],
                                       "international_status":  {
                                                                    "ema_status":  "Approved",
                                                                    "pmda_japan":  "Approved",
                                                                    "nmpa_china":  "Not Submitted",
                                                                    "health_canada":  "Approved",
                                                                    "tga_australia":  "Not Submitted",
                                                                    "ich_harmonization":  "ICH M4 CTD format recommended for global submissions"
                                                                },
                                       "recommendations":  [
                                                               "Consider Pre-IND meeting with FDA to align on development strategy",
                                                               "Estimated regulatory pathway: 505(b)(2) NDA",
                                                               "Plan for 42-month approval timeline",
                                                               "Engage regulatory affairs consultant for submission strategy"
                                                           ],
                                       "summary":  "Regulatory assessment for Humira: Compliance Grade A (Score: 100/100). Recommended pathway: 505(b)(2) NDA with estimated 42-month timeline. Safety profile: Low risk with 0 identified warning(s)."
                                   },
                    "patient_sentiment":  {
                                              "agent":  "PatientSentimentAgent",
                                              "molecule":  "Humira",
                                              "indication":  {
                                                                 "provider":  "openai",
                                                                 "model":  "gpt-4",
                                                                 "api_key":  null,
                                                                 "temperature":  0.7,
                                                                 "max_tokens":  4096,
                                                                 "privacy_level":  "standard",
                                                                 "data_residency":  "cloud",
                                                                 "capabilities":  {
                                                                                      "complex_reasoning":  true,
                                                                                      "multi_modal":  true,
                                                                                      "context_window":  128000
                                                                                  }
                                                             },
                                              "timestamp":  "2025-12-06T13:15:09.692856",
                                              "processing_time_ms":  0.21,
                                              "forum_sources_analyzed":  [
                                                                             "PatientLikeMe",
                                                                             "HealthUnlocked",
                                                                             "DailyStrength",
                                                                             "WebMD Community",
                                                                             "Reddit r/medicine",
                                                                             "Inspire Health Communities"
                                                                         ],
                                              "total_posts_analyzed":  2530,
                                              "date_range":  "Last 12 months",
                                              "overall_sentiment":  "Positive",
                                              "sentiment_breakdown":  {
                                                                          "positive":  "42%",
                                                                          "neutral":  "29%",
                                                                          "negative":  "29%"
                                                                      },
                                              "sentiment_trend":  "Improving",
                                              "top_complaints":  [
                                                                     {
                                                                         "complaint":  "Humira causes severe nausea in the first week",
                                                                         "frequency":  28,
                                                                         "severity":  "High",
                                                                         "category":  "Side Effects"
                                                                     },
                                                                     {
                                                                         "complaint":  "Insurance doesn\u0027t cover the full cost - too expensive",
                                                                         "frequency":  22,
                                                                         "severity":  "High",
                                                                         "category":  "Cost/Access Issues"
                                                                     },
                                                                     {
                                                                         "complaint":  "Switched from Humira due to weight gain",
                                                                         "frequency":  21,
                                                                         "severity":  "High",
                                                                         "category":  "Quality of Life Impact"
                                                                     },
                                                                     {
                                                                         "complaint":  "Takes months to see any real improvement",
                                                                         "frequency":  15,
                                                                         "severity":  "Medium",
                                                                         "category":  "Efficacy Concerns"
                                                                     },
                                                                     {
                                                                         "complaint":  "Injection site reactions are painful and long-lasting",
                                                                         "frequency":  11,
                                                                         "severity":  "Medium",
                                                                         "category":  "Administration Burden"
                                                                     }
                                                                 ],
                                              "complaint_severity_distribution":  {
                                                                                      "High":  3,
                                                                                      "Medium":  3,
                                                                                      "Low":  1
                                                                                  },
                                              "unmet_needs_identified":  [
                                                                             {
                                                                                 "need":  "Better-tolerated treatment option with fewer GI side effects",
                                                                                 "patient_quote":  "I wish there was something that worked without making me feel sick all day",
                                                                                 "prevalence":  "42% of discussions mention this",
                                                                                 "opportunity_size":  "High",
                                                                                 "addressable":  true
                                                                             },
                                                                             {
                                                                                 "need":  "Once-weekly or once-monthly dosing instead of daily",
                                                                                 "patient_quote":  "It\u0027s exhausting to remember to take pills every single day",
                                                                                 "prevalence":  "28% of discussions mention this",
                                                                                 "opportunity_size":  "High",
                                                                                 "addressable":  true
                                                                             },
                                                                             {
                                                                                 "need":  "More affordable generic alternatives",
                                                                                 "patient_quote":  "My copay is $300/month - I can\u0027t afford to stay on this",
                                                                                 "prevalence":  "35% of discussions mention this",
                                                                                 "opportunity_size":  "Medium",
                                                                                 "addressable":  true
                                                                             },
                                                                             {
                                                                                 "need":  "Treatment that doesn\u0027t cause weight changes",
                                                                                 "patient_quote":  "I\u0027ve gained 20 pounds since starting - it\u0027s affecting my mental health",
                                                                                 "prevalence":  "22% of discussions mention this",
                                                                                 "opportunity_size":  "High",
                                                                                 "addressable":  true
                                                                             },
                                                                             {
                                                                                 "need":  "Faster onset of action",
                                                                                 "patient_quote":  "Waiting 6-8 weeks to know if it\u0027s working is incredibly stressful",
                                                                                 "prevalence":  "18% of discussions mention this",
                                                                                 "opportunity_size":  "Medium",
                                                                                 "addressable":  false
                                                                             }
                                                                         ],
                                              "unmet_needs_count":  5,
                                              "unmet_needs_priority_score":  60,
                                              "market_opportunity_signal":  "Strong",
                                              "treatment_burden_score":  7,
                                              "burden_factors":  [
                                                                     {
                                                                         "factor":  "Complex dosing regimen",
                                                                         "impact":  "High",
                                                                         "patient_feedback":  "Multiple daily doses are hard to manage"
                                                                     },
                                                                     {
                                                                         "factor":  "Required monitoring",
                                                                         "impact":  "Medium",
                                                                         "patient_feedback":  "Monthly blood tests are inconvenient"
                                                                     },
                                                                     {
                                                                         "factor":  "Dietary restrictions",
                                                                         "impact":  "Medium",
                                                                         "patient_feedback":  "Can\u0027t eat certain foods while on medication"
                                                                     },
                                                                     {
                                                                         "factor":  "Storage requirements",
                                                                         "impact":  "High",
                                                                         "patient_feedback":  "Refrigeration makes travel difficult"
                                                                     }
                                                                 ],
                                              "quality_of_life_impact":  "Significant",
                                              "patient_journey_insights":  {
                                                                               "diagnosis_to_treatment":  {
                                                                                                              "avg_time":  "4-6 months",
                                                                                                              "pain_points":  [
                                                                                                                                  "Multiple doctor visits before diagnosis",
                                                                                                                                  "Insurance pre-authorization delays",
                                                                                                                                  "Specialist availability issues"
                                                                                                                              ]
                                                                                                          },
                                                                               "treatment_initiation":  {
                                                                                                            "barriers":  [
                                                                                                                             "Cost concerns",
                                                                                                                             "Fear of side effects",
                                                                                                                             "Skepticism about efficacy"
                                                                                                                         ],
                                                                                                            "dropout_rate":  "17% within first month"
                                                                                                        },
                                                                               "long_term_adherence":  {
                                                                                                           "avg_adherence_rate":  "57%",
                                                                                                           "common_discontinuation_reasons":  [
                                                                                                                                                  "Side effects",
                                                                                                                                                  "Perceived lack of benefit",
                                                                                                                                                  "Cost",
                                                                                                                                                  "Forgetfulness"
                                                                                                                                              ]
                                                                                                       }
                                                                           },
                                              "competitor_sentiment":  {

                                                                       },
                                              "key_insights":  [
                                                                   "Patient sentiment is positive with improving trend",
                                                                   "Identified 5 distinct unmet needs with strong market opportunity",
                                                                   "Top complaint category: Side Effects (3 high-severity issues)",
                                                                   "HIGH OPPORTUNITY: Multiple addressable unmet needs identified - strong case for differentiated product"
                                                               ],
                                              "recommendations":  [
                                                                      "Address \u0027Better-tolerated treatment option with fewer GI side effects\u0027 - affects 42% of discussions mention this",
                                                                      "Address \u0027Once-weekly or once-monthly dosing instead of daily\u0027 - affects 28% of discussions mention this",
                                                                      "Address \u0027More affordable generic alternatives\u0027 - affects 35% of discussions mention this",
                                                                      "Prioritize formulation/delivery improvements to reduce treatment burden",
                                                                      "Develop patient-centric communication addressing top concerns",
                                                                      "Consider patient advocacy group partnerships for market access",
                                                                      "Build real-world evidence program to address efficacy skepticism"
                                                                  ],
                                              "summary":  "Patient sentiment analysis for Humira: Overall sentiment is Positive with Improving trend. Identified 5 unmet needs with Strong market opportunity signal. Treatment burden score: 7/10 (Significant QoL impact). Key opportunity: Address tolerability and convenience gaps."
                                          },
                    "esg":  {
                                "agent":  "ESGSustainabilityAgent",
                                "molecule":  "Humira",
                                "timestamp":  "2025-12-06T13:15:09.694146",
                                "processing_time_ms":  1.15,
                                "overall_esg_score":  67.4,
                                "esg_rating":  "A",
                                "esg_trend":  "Declining",
                                "environmental_score":  55.2,
                                "social_score":  77,
                                "governance_score":  73.5,
                                "suppliers_analyzed":  8,
                                "supplier_esg_scores":  [
                                                            {
                                                                "name":  "api_key",
                                                                "country":  "Japan",
                                                                "environmental_score":  77,
                                                                "social_score":  81,
                                                                "governance_score":  72,
                                                                "certifications":  [
                                                                                       "EcoVadis Silver"
                                                                                   ],
                                                                "carbon_footprint":  "Medium",
                                                                "renewable_energy_pct":  49,
                                                                "composite_esg_score":  77.2,
                                                                "esg_rating":  "AA",
                                                                "recommendation":  "Preferred"
                                                            },
                                                            {
                                                                "name":  "model",
                                                                "country":  "Germany",
                                                                "environmental_score":  69,
                                                                "social_score":  74,
                                                                "governance_score":  88,
                                                                "certifications":  [
                                                                                       "WHO-GMP",
                                                                                       "SA8000"
                                                                                   ],
                                                                "carbon_footprint":  "High",
                                                                "renewable_energy_pct":  21,
                                                                "composite_esg_score":  75.5,
                                                                "esg_rating":  "AA",
                                                                "recommendation":  "Preferred"
                                                            },
                                                            {
                                                                "name":  "privacy_level",
                                                                "country":  "China",
                                                                "environmental_score":  62,
                                                                "social_score":  80,
                                                                "governance_score":  80,
                                                                "certifications":  [
                                                                                       "WHO-GMP",
                                                                                       "SA8000"
                                                                                   ],
                                                                "carbon_footprint":  "Low",
                                                                "renewable_energy_pct":  35,
                                                                "composite_esg_score":  72.8,
                                                                "esg_rating":  "A",
                                                                "recommendation":  "Acceptable"
                                                            },
                                                            {
                                                                "name":  "max_tokens",
                                                                "country":  "Germany",
                                                                "environmental_score":  73,
                                                                "social_score":  70,
                                                                "governance_score":  75,
                                                                "certifications":  [
                                                                                       "ISO 14001",
                                                                                       "SA8000",
                                                                                       "WHO-GMP"
                                                                                   ],
                                                                "carbon_footprint":  "High",
                                                                "renewable_energy_pct":  55,
                                                                "composite_esg_score":  72.5,
                                                                "esg_rating":  "A",
                                                                "recommendation":  "Acceptable"
                                                            },
                                                            {
                                                                "name":  "temperature",
                                                                "country":  "USA",
                                                                "environmental_score":  58,
                                                                "social_score":  78,
                                                                "governance_score":  86,
                                                                "certifications":  [
                                                                                       "EcoVadis Silver",
                                                                                       "WHO-GMP",
                                                                                       "ISO 14001"
                                                                                   ],
                                                                "carbon_footprint":  "High",
                                                                "renewable_energy_pct":  54,
                                                                "composite_esg_score":  72,
                                                                "esg_rating":  "A",
                                                                "recommendation":  "Acceptable"
                                                            },
                                                            {
                                                                "name":  "data_residency",
                                                                "country":  "USA",
                                                                "environmental_score":  70,
                                                                "social_score":  76,
                                                                "governance_score":  64,
                                                                "certifications":  [
                                                                                       "ISO 14001"
                                                                                   ],
                                                                "carbon_footprint":  "High",
                                                                "renewable_energy_pct":  20,
                                                                "composite_esg_score":  70.6,
                                                                "esg_rating":  "A",
                                                                "recommendation":  "Acceptable"
                                                            },
                                                            {
                                                                "name":  "provider",
                                                                "country":  "Germany",
                                                                "environmental_score":  55,
                                                                "social_score":  86,
                                                                "governance_score":  61,
                                                                "certifications":  [
                                                                                       "SA8000",
                                                                                       "WHO-GMP",
                                                                                       "EcoVadis Silver"
                                                                                   ],
                                                                "carbon_footprint":  "Low",
                                                                "renewable_energy_pct":  20,
                                                                "composite_esg_score":  67.3,
                                                                "esg_rating":  "A",
                                                                "recommendation":  "Acceptable"
                                                            },
                                                            {
                                                                "name":  "capabilities",
                                                                "country":  "Japan",
                                                                "environmental_score":  58,
                                                                "social_score":  71,
                                                                "governance_score":  62,
                                                                "certifications":  [
                                                                                       "ISO 14001"
                                                                                   ],
                                                                "carbon_footprint":  "Low",
                                                                "renewable_energy_pct":  59,
                                                                "composite_esg_score":  63.5,
                                                                "esg_rating":  "BBB",
                                                                "recommendation":  "Acceptable"
                                                            }
                                                        ],
                                "best_esg_supplier":  {
                                                          "name":  "api_key",
                                                          "esg_score":  77.2,
                                                          "rating":  "AA",
                                                          "key_strengths":  [
                                                                                "EcoVadis Silver"
                                                                            ]
                                                      },
                                "suppliers_requiring_improvement":  [
                                                                        {
                                                                            "name":  "capabilities",
                                                                            "score":  63.5,
                                                                            "issues":  "Acceptable"
                                                                        }
                                                                    ],
                                "carbon_footprint_analysis":  {
                                                                  "total_emissions":  "1792 tons CO2e/year",
                                                                  "intensity_rating":  "High",
                                                                  "scope_1":  "268 tons (Direct)",
                                                                  "scope_2":  "448 tons (Energy)",
                                                                  "scope_3":  "1075 tons (Supply Chain)",
                                                                  "reduction_potential":  "33% achievable with green suppliers",
                                                                  "carbon_offset_cost":  "$44800/year",
                                                                  "net_zero_pathway":  {
                                                                                           "target_year":  2035,
                                                                                           "current_progress":  "31%",
                                                                                           "key_initiatives":  [
                                                                                                                   "Supplier renewable energy transition",
                                                                                                                   "Logistics optimization",
                                                                                                                   "Process efficiency improvements"
                                                                                                               ]
                                                                                       }
                                                              },
                                "total_carbon_emissions":  "1792 tons CO2e/year",
                                "carbon_intensity":  "High",
                                "scope_3_emissions":  "1075 tons (Supply Chain)",
                                "ethical_sourcing_score":  77,
                                "labor_practice_concerns":  [

                                                            ],
                                "fair_trade_compliance":  "Compliant",
                                "environmental_compliance":  {
                                                                 "reach_compliance":  "Compliant",
                                                                 "rohs_compliance":  "Compliant",
                                                                 "waste_management":  "Adequate",
                                                                 "water_usage_rating":  "High Impact",
                                                                 "hazardous_materials":  {
                                                                                             "present":  true,
                                                                                             "properly_managed":  true,
                                                                                             "disposal_certified":  true
                                                                                         },
                                                                 "environmental_incidents":  1,
                                                                 "certifications_held":  [
                                                                                             "ISO 14001",
                                                                                             "Green Chemistry Certification",
                                                                                             "EMAS",
                                                                                             "ISO 50001"
                                                                                         ]
                                                             },
                                "social_impact_assessment":  {
                                                                 "community_investment":  "$366K annually",
                                                                 "jobs_supported":  "2204 direct + indirect",
                                                                 "diversity_score":  84,
                                                                 "health_safety_incidents":  4,
                                                                 "employee_satisfaction":  "79%",
                                                                 "training_hours_per_employee":  58,
                                                                 "local_sourcing_percentage":  "26%"
                                                             },
                                "governance_assessment":  {
                                                              "overall_score":  73.5,
                                                              "board_independence":  "67%",
                                                              "ethics_policy":  "Comprehensive",
                                                              "whistleblower_protection":  "Strong",
                                                              "anti_corruption_training":  "95% completion",
                                                              "supplier_audits_completed":  "98%",
                                                              "transparency_rating":  "A"
                                                          },
                                "esg_risk_level":  "Medium",
                                "identified_risks":  [
                                                         {
                                                             "risk":  "High carbon intensity may face regulatory pressure",
                                                             "category":  "Environmental",
                                                             "severity":  "Medium",
                                                             "likelihood":  "High"
                                                         },
                                                         {
                                                             "risk":  "Increasing ESG disclosure requirements (EU CSRD)",
                                                             "category":  "Regulatory",
                                                             "severity":  "Medium",
                                                             "likelihood":  "High"
                                                         },
                                                         {
                                                             "risk":  "Investor ESG screening may limit capital access",
                                                             "category":  "Financial",
                                                             "severity":  "Medium",
                                                             "likelihood":  "Medium"
                                                         }
                                                     ],
                                "mitigation_strategies":  [
                                                              "Implement supplier ESG audit program",
                                                              "Set science-based carbon reduction targets",
                                                              "Enhance ESG disclosure and reporting",
                                                              "Diversify supplier base to reduce concentration risk"
                                                          ],
                                "green_sourcing_score":  {
                                                             "score":  52.7,
                                                             "rating":  "Needs Improvement",
                                                             "components":  {
                                                                                "carbon_efficiency":  40,
                                                                                "ethical_sourcing":  77,
                                                                                "renewable_energy":  39.1
                                                                            },
                                                             "benchmark":  "Industry average: 58",
                                                             "improvement_potential":  "+14 points achievable"
                                                         },
                                "recommendations":  [
                                                        "Engage 1 low-ESG suppliers in improvement programs or seek alternatives",
                                                        "Target 33% achievable with green suppliers carbon reduction through green supplier transition",
                                                        "Implement quarterly ESG supplier scorecards",
                                                        "Set 2030 net-zero supply chain commitment",
                                                        "Join industry ESG initiatives (e.g., PSCI)",
                                                        "Enhance ESG KPIs in supplier contracts",
                                                        "Publish annual sustainability report aligned with GRI/SASB"
                                                    ],
                                "ey_framework_alignment":  {
                                                               "framework":  "EY ESG Integration Framework",
                                                               "alignment_score":  "83%",
                                                               "key_metrics_tracked":  [
                                                                                           "Carbon Emissions (Scope 1-3)",
                                                                                           "Supplier Diversity Index",
                                                                                           "Ethics \u0026 Compliance Score",
                                                                                           "Employee Wellbeing Index",
                                                                                           "Community Impact Value"
                                                                                       ],
                                                               "reporting_standards":  [
                                                                                           "GRI",
                                                                                           "SASB",
                                                                                           "TCFD",
                                                                                           "CDP"
                                                                                       ],
                                                               "materiality_assessment":  "Completed",
                                                               "stakeholder_engagement":  "Active",
                                                               "sdg_alignment":  [
                                                                                     "SDG 3: Good Health",
                                                                                     "SDG 12: Responsible Consumption",
                                                                                     "SDG 13: Climate Action"
                                                                                 ]
                                                           },
                                "summary":  "ESG assessment for Humira supply chain: Overall ESG Rating A (Score: 67.4/100). Carbon intensity: High. ESG risk level: Medium. Environmental: 55.2, Social: 77.0, Governance: 73.5. Trend: Declining."
                            },
                    "knowledge_graph":  {
                                            "nodes":  160,
                                            "edges":  445,
                                            "key_pathways":  [
                                                                 "PI3K/AKT",
                                                                 "MAPK/ERK",
                                                                 "JAK/STAT",
                                                                 "NF-κB"
                                                             ]
                                        },
                    "processingTimeMs":  6047
                },
    "metadata":  {
                     "timestamp":  "2025-12-06T07:45:09.702Z",
                     "version":  "1.0.0",
                     "complianceMode":  "STANDARD"
                 }
}
